ADAMTS8 and breast cancer: Indeed, the expression of ADAMTS8, 9, 12, 16, 18 and 19 was found to be reduced through methylation in the CpG islands in the promoter region in LC, BC, gastric (GC), colorectal (CRC), PDAC, prostate cancer (PC) and renal cell carcinoma (RCC)[19–28].